You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report

Article info

Article menu

Download PDFPDF

Commentary
When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report

Authors

  • Marie-Léa Gauci U976, INSERM, Paris, Île-de-France, France Université Paris Diderot-Paris VII, Université Sorbonne Paris Cité, Paris, Île-de-France, France AP-HP, Département de Dermatologie, Hôpital Saint-Louis, Paris, Île-de-France, France PubMed articlesGoogle scholar articles
  • Barouyr Baroudjian AP-HP, Département de Dermatologie, Hôpital Saint-Louis, Paris, Île-de-France, France PubMed articlesGoogle scholar articles
  • Celeste Lebbe U976, INSERM, Paris, Île-de-France, France Université Paris Diderot-Paris VII, Université Sorbonne Paris Cité, Paris, Île-de-France, France AP-HP, Département de Dermatologie, Hôpital Saint-Louis, Paris, Île-de-France, France PubMed articlesGoogle scholar articles
  • Olivier Roux Service d'hépatologie et réanimation hépatique, DMU DIGEST, AP-HP Nord, Hôpital Beaujon, Clichy, France PubMed articlesGoogle scholar articles

Citation

Gauci M, Baroudjian B, Lebbe C, et al
When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report
Journal for ImmunoTherapy of Cancer 2021;9:e002337. doi: 10.1136/jitc-2021-002337
Online issue publication 
February 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.